All Blogs

Dec 28, 2022

Over the past few years, the growth and development in electronics, micro and nano-fabrication, and wireless technology have significantly enhanced the quality and effectiveness of healthcare delivery systems, and treatment outcomes and led to various insights in the biological investigations through research and d...

Dec 27, 2022

FDA Approves Gilead Sciences’ Sunlenca Sunlenca, a Gilead Sciences therapy for people with multidrug-resistant (MDR) HIV infection that only needs to be taken twice a year, has received FDA approval for the second time of asking. Sunlenca, which is based on the HIV capsid inhibitor lenacapavir, is intended to be...

Dec 26, 2022

Limbal Stem Cell Deficiency (LSCD) is a rare, progressive ocular surface disorder that results in conjunctivalization and neovascularization of the corneal surface. Ocular discomfort, reduced visual acuity, and photophobia are all symptoms of LSCD, which can be brought on by severe ocular surface illness.  ...

Dec 22, 2022

Medtronic Announced First Patient Enrolment for Hugo™ Robotic-Assisted Surgery System in US Clinical Trial On December 15, 2022, Medtronic, a global healthcare technology leader, announced that the first patient was enrolled in the Expand URO US clinical trial for the Hugo™ robotic-assisted surgery...

Dec 21, 2022

Nuclear Medicine is an integral part of today’s healthcare delivery system and provides an immense benefit to patient care. Over the past four-five decades, there has been intense growth in the Nuclear Medicine Market owing to the development of various radionuclide and radio-labeled compounds and equipment. The ap...

Dec 20, 2022

AbbVie Secures Fourth FDA Approval for Vraylar AbbVie has received its fourth FDA approval for Vraylar, adding major depressive disorder (MDD) adjunctive therapy to a list that includes schizophrenia and manic and depressive episodes in bipolar disorder. According to AbbVie, the approval makes Vraylar (cariprazi...

Dec 23, 2022

Head and neck cancer is a complex indication and is common among men and people over 50 and accounts for 3–5% of all cancers in the US. As per the assessment done by DelveInsight, there were approximately 158K incident cases of head and neck cancer in the 7MM in 2021. Among the EU5 countries, Germany had the highes...

Sep 04, 2024

Nonalcoholic steatohepatitis is one of the most common causes of liver disease in the United States. As per the National Institute of Diabetes and Digestive and Kidney Diseases, only a small number of NAFLD patients possess NASH. In 2023, the United States reported the highest number of diagnosed prevalent cases of...

Dec 19, 2022

American Society of Hematology (ASH) presented fresh abstracts from a strong portfolio and pipeline of cutting-edge treatment platforms for cancer and blood diseases, underscoring the significance of our audacious science in research. Delveinsight has provided a summary of some of the key abstracts and their result...

Dec 19, 2022

The American Society of Hematology (ASH) Annual Meeting this year presented abstracts showcasing new data from across its bispecific antibodies clinical pipeline, demonstrating the companies’ commitment to redefining care for patients with DLBCL.  Recently, off-the-shelf bispecific antibodies have grow...